Introduction This study examined the relative efficacy of growth factor therapies in healing
diabetes‐related foot ulcers (DFU). Methods PubMed and Cochrane databases were …

Aims Topical growth factors accelerate wound healing in patients with diabetic foot ulcers
(DFU). Due to the absence of head‐to‐head comparisons, we carried out Bayesian network …

Context Diabetes mellitus is associated with morbid complications such as diabetic foot
ulcers (DFUs) that may lead to amputations or mortality if not managed adequately …

Background: Diabetic foot ulcers (DFUs) are a life-threatening ailment caused by diabetes.
Several growth factors, as well as their various combinations, have shown promising effect …

Background It is critical that interventions used to enhance the healing of chronic foot ulcers
in diabetes are backed by high‐quality evidence and cost‐effectiveness. In previous years …

Background Foot ulcers are a major complication of diabetes mellitus, often leading to
amputation. Growth factors derived from blood platelets, endothelium, or macrophages …

The management of diabetic foot ulcers (DFU) remains a challenge, and there is continuing
uncertainty concerning optimal approaches to wound healing. The International Working …

Diabetic foot ulcers (DFUs) are one the common complications of diabetes mellitus. Many
trials were performed to evaluate the effect of recombinant human epidermal growth factor …

Background. Recombinant proteins and growth factors are emerging therapies for diabetic
foot ulcers. Despite several clinical reports, there has been no comprehensive and …

The outcome of management of diabetic foot ulcers remains a challenge, and there remains
continuing uncertainty concerning optimal approaches to management. It is for these …